Xue Jun Su
Directeur/Membre du Conseil chez SSY GROUP LIMITED
Fortune : 15 M $ au 30/04/2024
Postes actifs de Xue Jun Su
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SSY GROUP LIMITED | Directeur/Membre du Conseil | 15/12/2014 | - |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
 New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Directeur/Membre du Conseil | 07/01/2007 | - |
Historique de carrière de Xue Jun Su
Anciens postes connus de Xue Jun Su
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Shijiazhuang No 1 Pharmaceutical Factory | Corporate Officer/Principal | 01/01/1990 | - |
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
 Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Directeur/Membre du Conseil | 01/01/2002 | - |
| Président | - | - | |
| Corporate Officer/Principal | 01/01/2002 | - |
Formation de Xue Jun Su
| Hebei Normal University | Undergraduate Degree |
Statistiques
Internationale
| Chine | 4 |
| Hong Kong | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Chairman | 1 |
Sectorielle
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SSY GROUP LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
Shijiazhuang No. 4 Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shijiazhuang No.4 Pharmaceutical Co., Ltd. is a pharmceutical company in China. It offers medicines in forms of infusions, capsules, granules, tablets & oral liquids among others. The company was founded in 1948 and is headquartered in Hebei, CN. | Health Technology |
| Shijiazhuang No 1 Pharmaceutical Factory | |
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd.
New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. Financial ConglomeratesFinance Part of SSY Group Ltd., New Orient Investments Pharmaceutical Holding (Hong Kong) Ltd. operates as an investment holding Samoan company. The company is based in Chaoyan, Samoa. New Orient Investments Pharmaceutical Holding (Hong Kong was acquired by SSY Group Ltd. from CMP Group Ltd. (Samoa) on June 29, 2007 for $91.31 million. | Finance |
- Bourse
- Insiders
- Xue Jun Su
- Expérience